Prescribing information can be found at the bottom of the page

Making younger women aware of intrauterine contraception

Tailoring contraceptive choice, understanding the value of remote counselling and consultations and advice for offering Kyleena (19.5mg levonorgestrel)

     

    Part 1 - Manchester experience with and advice for offering Kyleena® (19.5mg intrauterine delivery system Levonorgestrel)

     
    Author/Uploaded by

    Dr Asha Kasliwal, Clinical Director and Consultant in Community Gynaecology & Reproductive Healthcare

     

    This recorded webinar is part of the “Women’s Health Matters” Medical Educational programme which aims to inspire, update and support healthcare professionals with an interest in women’s health.

     

    Learning objectives:

    • Manchester experience with and advice for offering Kyleena® (19.5mg intrauterine delivery system Levonorgestrel)

     

    Part 2 - A year of coil activity in Leeds sexual health

     
    Author/Uploaded by

    By Dr Radhika Vohra, NHS and Private GP



     



    Learning objectives:




    • The contraceptive needs for younger patients
    • The effect of COVID-19 on contraception policy
    • What is Kyleena (19.5mg levonorgestrel) and when is it indicated?
    • Differences between Mirena (52mg levonorgestrel) and Kyleena (19.5mg levonorgestrel)
    • How to tackle common myths regarding IUDs
    • Factors affecting contraceptive choices in younger patients

     

    Part 3 - A tailored approach to contraception

    Watch now Watch now
    Part 1 - Manchester experience with and advice for offering Kyleena® (19.5mg intrauterine delivery system Levonorgestrel)

    Dr Asha Kasliwal, Clinical Director and Consultant in Community Gynaecology & Reproductive Healthcare

      Watch now
    Part 2 - A year of coil activity in Leeds sexual health

    Dr Madeleine Crow, ST5 registrar in Community Sexual and Reproductive Health

      Watch now
    Part 3 - A tailored approach to contraception

    Dr Farah Chaudhry, Consultant in Sexual and Reproductive Health in Leeds Community Healthcare NHS Trust

    Our speakers

    Latest videos

    Bayer IUS supporting women's reproductive lifecycle and beyond
    Watch now
    Menopause case 8 - Donna
    Watch now
    Developing an effective IUS/D service for 2021/2 and beyond
    Watch now

    RP-PF-WHC-GB-0972 May 2022

    Reporting adverse events and quality complaints

     

    Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Bayer plc.

     

    If you want to report an adverse event or quality complaint, reports can be directed to: Tel: 011820‍63500 or email: pvuk@bayer.com

     

    Further information is available on the “contact” tab at www.bayer.co.uk.